Montefiore Hospital Clinical and Translational Research Center
Welcome,         Profile    Billing    Logout  
 8 Trials 
6 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Donahoe, Michael
IMPALA-2, NCT04544293 / 2020-001263-85: Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

Active, not recruiting
3
160
Europe, Canada, Japan, US, RoW
Molgramostim, Recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF), Placebo
Savara Inc., Savara ApS,
Autoimmune Pulmonary Alveolar Proteinosis
06/24
06/25
Corcoran, Timothy E
NCT05755932: Study to Assess Effect of HFO MDI Propellant on Mucociliary Clearance Compared to HFA MDI Propellant in Healthy Participants

Recruiting
3
30
US
HFO MDI, Propellant in MDI, HFA MDI
AstraZeneca
Mucociliary Clearance
07/24
07/24
Chan, Stephen L
SIERRA, NCT05883644: Durvalumab and Tremelimumab as First Line Treatment in Participants With Advanced Hepatocellular Carcinoma (HCC)

Recruiting
3
110
Europe, Japan, US, RoW
Durvalumab, Tremelimumab
AstraZeneca
Advanced Hepatocellular Carcinoma
06/25
12/25
PARTNER, NCT03150576: Platinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor for Neoadjuvant Treatment of Triple Negative Breast Cancer and/or Germline BRCA Positive Breast Cancer

Recruiting
2/3
780
Europe
Olaparib, Lynparza, Paclitaxel and Carboplatin, Taxol and Paraplatin
Cambridge University Hospitals NHS Foundation Trust, AstraZeneca, Cancer Research UK
Breast Cancer
06/24
06/34
NCT05452889: PET Image in PAH Patients

Recruiting
1
71
US
18F-FGLN PET Imaging, (18F)FPGLU
Stephen Y. Chan, Bayer, National Heart, Lung, and Blood Institute (NHLBI)
Pulmonary Arterial Hypertension
12/24
12/25
Aaraj, Yassmin Al
NCT05452889: PET Image in PAH Patients

Recruiting
1
71
US
18F-FGLN PET Imaging, (18F)FPGLU
Stephen Y. Chan, Bayer, National Heart, Lung, and Blood Institute (NHLBI)
Pulmonary Arterial Hypertension
12/24
12/25

Download Options